Complementary serum test of antibodies to Epstein-Barr virus nuclear antigen-1 and early antigen: A possible alternative for primary screening of nasopharyngeal carcinoma
- 31 August 2008
- journal article
- Published by Elsevier BV in Oral Oncology
- Vol. 44 (8), 784-792
- https://doi.org/10.1016/j.oraloncology.2007.10.003
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- The 30-bp Deletion of Epstein-Barr Virus Latent Membrane Protein-1 Gene Has No Effect in Nasopharyngeal CarcinomaThe Laryngoscope, 2006
- Treatment results for nasopharyngeal carcinoma in the modern era: The Hong Kong experienceInternational Journal of Radiation Oncology*Biology*Physics, 2005
- Laboratory markers of tumor burden in nasopharyngeal carcinoma: A comparison of viral load and serologic tests for Epstein‐Barr virusInternational Journal of Cancer, 2004
- Quantification of Plasma Epstein–Barr Virus DNA in Patients with Advanced Nasopharyngeal CarcinomaThe New England Journal of Medicine, 2004
- Phase III Study of Concurrent Chemoradiotherapy Versus Radiotherapy Alone for Advanced Nasopharyngeal Carcinoma: Positive Effect on Overall and Progression-Free SurvivalJournal of Clinical Oncology, 2003
- Long-term survival of nasopharyngeal carcinoma following concomitant radiotherapy and chemotherapyInternational Journal of Radiation Oncology*Biology*Physics, 2000
- ELISA for the detection of serum and saliva IgA against the BMRFI gene product of Epstein-Barr virusJournal of Medical Virology, 1996
- A possible prognostic role of immunoglobulin-G antibody against recombinant Epstein-Barr virus BZLF-1 transactivator protein ZEBRA in patients with nasopharyngeal carcinomaCancer, 1994
- Epstein-Barr-virus-specific IgA and IgG serum antibodies in nasopharyngeal carcinomaBritish Journal of Cancer, 1976
- Epstein‐barr virus‐specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinomaInternational Journal of Cancer, 1976